Skip to main content
background gradient

Volume 14Issue 8

Editorial

Open Access
Crossing borders: the need for empirical evidence of real-world evidence transportability in oncology
  • Caitlin Clunie-O'Connor,
  • Per-Olof Thuresson,
  • Elizabeth Masters,
  • Aliki Taylor,
  • Mats Rosenlund,
  • Philani Mpofu, and
  • Blythe Adamson
e250053
Published Online:10 July 2025
Preview Abstract

Industry Update

Open Access
Access in all areas? A round up of developments in market access and health technology assessment: part 8
  • Sreeram V Ramagopalan and
  • Annie Jullien Pannelay
e250091
Published Online:17 June 2025
Preview Abstract

Plain Language Summary of Publication

Open Access
Long-term effectiveness and safety of ravulizumab in paroxysmal nocturnal hemoglobinuria: a plain language summary
  • Celso Arrais,
  • Natalia Carnelutto, and
  • Jheremy Reyes
e250022
Published Online:4 July 2025
Preview Abstract

Protocol

Open Access
A protocol for three observational cohort studies evaluating adverse outcomes, excess costs and repeat procedures after surgery for breast cancer in the USA
  • Sam E Wing,
  • Yuki Liu,
  • Jonathan C Johnson,
  • Kristin J Moore, and
  • Feibi Zheng
e250013
Published Online:14 July 2025
Preview Abstract

Short Report

Open Access
Cost impact of Bruton’s tyrosine kinase inhibitor selection in Medicare patients with chronic lymphocytic leukemia
  • Adam S Kittai,
  • Dipen A Patel,
  • Jason Shafrin,
  • Nadine Zawadzki,
  • Vikram S Shetty,
  • Yazan K Barqawi, and
  • Joanna M Rhodes
e250035
Published Online:23 June 2025
Preview Abstract

Research Article

Open Access
Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema
  • Sarah Walsh,
  • Anja Haltner,
  • Meaghan Bartlett,
  • John Sears,
  • Yinglei Li,
  • Maebh Kelly,
  • Simona Gavata-Steiger,
  • Chiara Nenci,
  • Iris Jacobs,
  • Ingo Pragst,
  • Neelanjana Ray, and
  • Imtiaz A Samjoo
e240237
Published Online:10 July 2025
Preview Abstract
Open Access
Rivaroxaban versus low-molecular-weight heparins for short- and long-term prognosis in patients with deep vein thrombosis after spontaneous intracranial hemorrhage
  • Jingfan Li,
  • Qi Song,
  • Gaopan Zhang,
  • Guannan Tong,
  • Chengyu Bian,
  • Huimei Zhang,
  • Hulin Zheng, and
  • Yafei Wang
e250030
Published Online:11 July 2025
Preview Abstract
Open Access
Real-world phosphorodiamidate morpholino oligomer treatment patterns in Duchenne muscular dystrophy: a claims-based analysis
  • Shannon Grabich,
  • Brian Ung,
  • Aalok Nadkar,
  • Kathryn DeYoung,
  • James Signorovitch, and
  • Aravindhan Veerapandiyan
e250037
Published Online:18 July 2025
Preview Abstract